ALXO
Price
$1.22
Change
+$0.14 (+12.96%)
Updated
Sep 5 closing price
Capitalization
65.33M
61 days until earnings call
NKTX
Price
$2.26
Change
+$0.13 (+6.10%)
Updated
Sep 5 closing price
Capitalization
160.52M
60 days until earnings call
Interact to see
Advertisement

ALXO vs NKTX

Header iconALXO vs NKTX Comparison
Open Charts ALXO vs NKTXBanner chart's image
ALX Oncology Holdings
Price$1.22
Change+$0.14 (+12.96%)
Volume$827.91K
Capitalization65.33M
Nkarta
Price$2.26
Change+$0.13 (+6.10%)
Volume$437.49K
Capitalization160.52M
ALXO vs NKTX Comparison Chart in %
Loading...
ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALXO vs. NKTX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALXO is a Hold and NKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ALXO: $1.22 vs. NKTX: $2.26)
Brand notoriety: ALXO and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALXO: 81% vs. NKTX: 83%
Market capitalization -- ALXO: $65.33M vs. NKTX: $160.52M
ALXO [@Biotechnology] is valued at $65.33M. NKTX’s [@Biotechnology] market capitalization is $160.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALXO’s FA Score shows that 0 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • ALXO’s FA Score: 0 green, 5 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, NKTX is a better buy in the long-term than ALXO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALXO’s TA Score shows that 3 TA indicator(s) are bullish while NKTX’s TA Score has 3 bullish TA indicator(s).

  • ALXO’s TA Score: 3 bullish, 4 bearish.
  • NKTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both ALXO and NKTX are a bad buy in the short-term.

Price Growth

ALXO (@Biotechnology) experienced а +4.27% price change this week, while NKTX (@Biotechnology) price change was +6.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ALXO is expected to report earnings on Nov 06, 2025.

NKTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTX($161M) has a higher market cap than ALXO($65.3M). NKTX YTD gains are higher at: -9.237 vs. ALXO (-26.946). ALXO (-114.05M) and NKTX (-119.2M) have comparable annual earnings (EBITDA) . NKTX has more cash in the bank: 290M vs. ALXO (79.3M). ALXO has less debt than NKTX: ALXO (10M) vs NKTX (78.5M). ALXO (0) and NKTX (0) have equivalent revenues.
ALXONKTXALXO / NKTX
Capitalization65.3M161M41%
EBITDA-114.05M-119.2M96%
Gain YTD-26.946-9.237292%
P/E RatioN/AN/A-
Revenue00-
Total Cash79.3M290M27%
Total Debt10M78.5M13%
TECHNICAL ANALYSIS
Technical Analysis
ALXONKTX
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SBGOF15.020.36
+2.45%
Standard Bank Group Ltd.
BIOE0.09N/A
N/A
Bio Essence Corp.
AMDLY46.00N/A
N/A
Amada Co. Ltd.
ABXXF17.09N/A
-0.03%
ABAXX Technologies Inc.
BLOZF0.41N/A
-0.45%
Cannabix Technologies Inc.

ALXO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALXO has been loosely correlated with NUVB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ALXO jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALXO
1D Price
Change %
ALXO100%
+12.96%
NUVB - ALXO
34%
Loosely correlated
+14.04%
ZNTL - ALXO
33%
Poorly correlated
-1.13%
KOD - ALXO
32%
Poorly correlated
+23.04%
NKTX - ALXO
32%
Poorly correlated
+6.10%
MGNX - ALXO
31%
Poorly correlated
+3.09%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with FATE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
+6.10%
FATE - NKTX
48%
Loosely correlated
+3.81%
BEAM - NKTX
48%
Loosely correlated
+12.62%
SYRE - NKTX
47%
Loosely correlated
+0.06%
CRBU - NKTX
47%
Loosely correlated
+1.08%
IMNM - NKTX
44%
Loosely correlated
+7.35%
More